Skip to main content
. 2018 Oct 14;4:542–555. doi: 10.1016/j.trci.2018.09.001

Table 1.

Baseline characteristics for set 1 patients (number of subjects under different aHTN drug classes in set 1)

Group No. of years since the first record of aHTN drug use
0 1 2 3 4 5
No aHTN drug 218 182 99 53 36 34
Diuretics only 29 27 18 11 6 5
CCB only 25 22 13 12 7 1
RAAS only 79 72 47 29 17 8
Diuretics + RAAS 44 38 28 16 10 8
CCB + RAAS 31 29 23 17 11 6
Diuretics + CCB 7 5 4 3 4 2
Diuretics + CCB + RAAS 24 20 17 13 12 9
Other groups 160 142 108 63 42 30
Total 617 537 357 217 145 103

Abbreviations: aHTN, antihypertensive; CCB, calcium channel blocker; RAAS, renin-angiotensin-aldosterone system.